Pharmaceutical Technology

JUNE 20, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Drug Development 59

Drug Development Pharmaceutical Manufacturing Communication Hospitals 59

Pharmaceutical Technology

JUNE 11, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Communication 52

Communication Hospitals Packaging Vaccines 52

Pharmaceutical Technology

JUNE 11, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Communication 52

Communication Hospitals Packaging Vaccines 52

Pharmaceutical Technology

JUNE 11, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 20, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 11, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Communication 52

Communication Hospitals Packaging Vaccines 52

Pharmaceutical Technology

JUNE 13, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Communication 52

Communication Hospitals Vaccines Packaging 52

Pharmaceutical Technology

JUNE 6, 2023

With two historic FDA approvals for RSV vaccines in the last two months, this issue’s lead interview addresses the pertinent question of access— how to ensure eligible individuals across the world get this vaccine. Please check your email to download the Report.

Vaccines 52

Vaccines Communication 52

Pharmaceutical Technology

JUNE 16, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Communication 52

Communication Hospitals Vaccines Packaging 52

Pharmaceutical Technology

JUNE 13, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Labelling 52

Labelling Communication Hospitals Vaccines 52

Pharmaceutical Technology

JUNE 16, 2025

mRNA vaccine coverage on Pharmaceutical Technology (or Clinical Trials Arena) is supported by Trilink. Can pharma tariffs “Make America Manufacture Again”? Editorial content is independently produced and follows the highest standards of journalistic integrity. Give your business an edge with our leading industry insights.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Vaccines Communication Hospitals 52

Pharmaceutical Technology

JUNE 13, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Biosimilars 52

Biosimilars Communication Hospitals Vaccines 52

Pharmaceutical Technology

JUNE 12, 2025

Find out more The transaction will see BioNTech assimilate its former rival in the Covid-19 vaccine arena. By GlobalData Learn more about Strategic Intelligence In July 2024, CureVac streamlined its focus towards oncology after selling influenza and Covid-19 vaccine development to GSK in a deal worth nearly €1.5bn.

Vaccines 52

Vaccines Communication Hospitals Packaging 52

pharmaphorum

APRIL 30, 2021

Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. How to improve payer engagement with tailored value communication.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

Pharmaceutical Technology

JUNE 18, 2025

The vaccine specialist stated its EBITDA will be positively impacted, with an update occurring when the transaction closes. Bavarian Nordic won its PRV when its chikungunya vaccine Vimkunya was approved by the FDA in February 2025. Vimkunya is the second approved chikungunya vaccine in the US, with Valneva’s Ixchiq also at the market.

Vaccines 52

Vaccines Communication Hospitals Packaging 52

Pharmaceutical Technology

JUNE 16, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Labelling 52

Labelling Communication Hospitals Vaccines 52

Pharmaceutical Technology

JUNE 18, 2025

He said the cuts concerned redundancies caused by certain departments having their own legislative, communication staff, and in other departments like HR and procurement – which constitute about 10% of the entire agency staff. Can pharma tariffs “Make America Manufacture Again”?

Vaccines 52

Vaccines Communication Hospitals Drug Development 52

Digital Pharmacist

DECEMBER 15, 2022

CVS MinuteClinics provide lab testing, clinical services, COVID-19 testing, and vaccination with or without an appointment. However, vaccination is the most frequently conducted service in community pharmacies, therefore, every community pharmacy should possess vaccines in stock and prepare their pharmacists not to miss sales opportunities.

Community Pharmacies 98

Community Pharmacies Medication Therapy Management (MTM) Pharmacy Management Pharmacy Technician 98

pharmaphorum

FEBRUARY 26, 2021

Emma Sutcliffe from NexGen Healthcare Communications looks at how patient insights can bring the invisible challenges of living with a rare condition into plain view. Big pharma might have dominated COVID headlines with its vaccine drive, but behind the scenes an army of SMEs has allowed the UK to respond swiftly to the pandemic.

Vaccines 59

Vaccines Communication Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

DECEMBER 2, 2022

Read on for key stories from this year’s Frontiers Health conference in Italy, unlocking the promise of patient support programmes in oncology, supercharging communications with modular content, and much more. Create, approve, deploy: supercharging communications with modular content. Case study: Syneos Health and VBI Vaccines.

Communication 52

Communication Pharmaceutical Companies Vaccines Pharmaceutical Companies 52

pharmaphorum

SEPTEMBER 25, 2020

We look at the latest research and reflect on how COVID-19 has changed perceptions as industry races to develop new vaccines and therapies. WEGO Health, a worldwide network of over 100,000 patient leaders, has revealed how far the industry has to go before it wins over the population at large.

Vaccines 40

Vaccines Communication 40

Pharmaceutical Technology

JUNE 13, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Communication 95

Communication Hospitals Vaccines Packaging 95

Pharmaceutical Technology

JUNE 20, 2025

Unlike vaccines, the agency leaders see the modality as a path to prevent and cure disease – aligning with the current administration’s wider national health strategy. We may still continue to send you service-related and other non-promotional communications. Can pharma tariffs “Make America Manufacture Again”?

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 16, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Communication 52

Communication Research Laboratories Hospitals Vaccines 52

Pharmaceutical Technology

JUNE 16, 2025

We may still continue to send you service-related and other non-promotional communications. Can pharma tariffs “Make America Manufacture Again”? By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. For more information relating to our privacy practices, we invite you to review our privacy policy.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Communication Hospitals Vaccines 98

pharmaphorum

AUGUST 13, 2020

New York Magazine , the New York Times and The Economist amongst many other news organisations knocked down their paywalls for COVID-19-related coverage to keep readers informed in a rapidly changing and often confusing environment. Think you need to build manufacturing of a vaccine before you know what’s working.

Health and Personal Care Stores 112

Health and Personal Care Stores Vaccines Communication Pharmaceutical Companies 112

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . In the UK we have world leading genetic sequencing capabilities. “We

Drug Development 93

Drug Development Vaccines Documentation Communication 93

Pharmaceutical Technology

JUNE 13, 2025

Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. Until now, the vaccine was licensed for the prevention of lower respiratory tract disease (LRTD) caused by RSV in adults aged 60 years and older.

Vaccines 52

Vaccines Insurance Coverage and Processing Labelling Communication 52

Pharmaceutical Technology

JUNE 25, 2025

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump administration. Robert Barrie June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook RFK Jr has embarked on a mission to reset vaccine regulation and evidence generation in the US.

Vaccines 115

Vaccines Hospitals Packaging Communication 115

Pharmaceutical Technology

JUNE 10, 2025

Robert Barrie and Ross Law June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The removal ACIP members marks the most significant upheaval to the current vaccine landscape under Trump’s administration. Can pharma tariffs “Make America Manufacture Again”? lev radin via Shutterstock. lev radin via Shutterstock.

Vaccines 52

Vaccines Insurance Coverage and Processing Drug Pricing Immunization 52

Pharmaceutical Technology

JUNE 11, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Can pharma tariffs “Make America Manufacture Again”?

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Communication Hospitals Packaging 52